rs56386767

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_173354.5(SIK1):​c.2087C>T​(p.Pro696Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P696S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000020 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SIK1
NM_173354.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.359

Publications

3 publications found
Variant links:
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
SIK1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 30
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032420158).
BP6
Variant 21-43417007-G-A is Benign according to our data. Variant chr21-43417007-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIK1NM_173354.5 linkc.2087C>T p.Pro696Leu missense_variant Exon 14 of 14 ENST00000270162.8 NP_775490.2 P57059
SIK1XM_011529474.3 linkc.1940C>T p.Pro647Leu missense_variant Exon 13 of 13 XP_011527776.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIK1ENST00000270162.8 linkc.2087C>T p.Pro696Leu missense_variant Exon 14 of 14 1 NM_173354.5 ENSP00000270162.6 P57059

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
3938
Hom.:
0
Cov.:
0
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00734
AC:
455
AN:
61998
AF XY:
0.00763
show subpopulations
Gnomad AFR exome
AF:
0.0257
Gnomad AMR exome
AF:
0.00682
Gnomad ASJ exome
AF:
0.00499
Gnomad EAS exome
AF:
0.000137
Gnomad FIN exome
AF:
0.00257
Gnomad NFE exome
AF:
0.00379
Gnomad OTH exome
AF:
0.00797
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000198
AC:
1
AN:
50602
Hom.:
0
Cov.:
0
AF XY:
0.0000385
AC XY:
1
AN XY:
25990
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2970
American (AMR)
AF:
0.00
AC:
0
AN:
1086
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5248
South Asian (SAS)
AF:
0.00142
AC:
1
AN:
706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1710
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
338
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
32238
Other (OTH)
AF:
0.00
AC:
0
AN:
3864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.825
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
3954
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
1714
African (AFR)
AF:
0.00
AC:
0
AN:
1888
American (AMR)
AF:
0.00
AC:
0
AN:
202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
156
East Asian (EAS)
AF:
0.00
AC:
0
AN:
52
South Asian (SAS)
AF:
0.00
AC:
0
AN:
92
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
58
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1442
Other (OTH)
AF:
0.00
AC:
0
AN:
28
Alfa
AF:
0.00117
Hom.:
0
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.0155
AC:
56
ESP6500EA
AF:
0.00258
AC:
19
ExAC
AF:
0.00306
AC:
321
Asia WGS
AF:
0.00231
AC:
8
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 30 Benign:2
Dec 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 21, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
2.4
DANN
Benign
0.88
DEOGEN2
Benign
0.092
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.0032
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.36
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.92
N
REVEL
Benign
0.070
Sift
Benign
0.035
D
Sift4G
Benign
0.45
T
Polyphen
0.0
B
Vest4
0.038
MVP
0.11
MPC
0.45
ClinPred
0.0041
T
GERP RS
-1.5
Varity_R
0.029
gMVP
0.25
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56386767; hg19: chr21-44836887; COSMIC: COSV54260794; COSMIC: COSV54260794; API